• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHASKA DISCRETE MFG IO ACCESS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHASKA DISCRETE MFG IO ACCESS FERRITIN; RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN Back to Search Results
Model Number 33020
Device Problem Low Test Results (2458)
Patient Problem No Code Available (3191)
Event Date 02/13/2019
Event Type  Injury  
Manufacturer Narrative
Customer did not provide patient demographics such as date of birth, sex, weight, ethnicity or race.The access ferritin reagent was not returned for evaluation.A beckman laboratory system support (lss) was dispatched to the customer's site and performed a dilution test for the questioned sample on (b)(6) 2019 and the test result of the diluted sample was > 75000.0 ng/ml.The cause of this isolated event cannot be determined.Beckman coulter internal number: (b)(4).
 
Event Description
The customer reported low ferritin results for one patient sample.The result was generated on the laboratory's unicel dxi 800 access immunoassay system (serial number (b)(4)).The initial elevated ferritin result was released from the laboratory and the report was sent to the patient.The patient received treatment based on the initial result on (b)(6) 2019.The details of the treatment were not provided.The patient¿s dosage of medication was adjusted after reporting of the second lower result on (b)(6) 2019.The details of the treatment were not provided.The patient was sent for emergency care.On (b)(6) 2019, the patient was diagnosed with hemophagocytic syndrome.The customer did not report any additional change or impact to patient care or treatment in association with this event.The customer reported that quality control (qc), calibration and system check were performing within assay and instrument specifications at the time of the event.Information on the collection and processing of the patient sample is not available.No issues with sample integrity were reported.
 
Manufacturer Narrative
Additional information provided on april 29th, 2019 from customer: on (b)(6) 2019, 23 month old child, the patient went to out-patient due to fever and rash.The patient had fever for two weeks.The patient took the dexamethasone, cephalosporin as the anti-infective treatment in local hospital, however, the patient was not getting better.Then, the patient was transferred to (b)(6) hospital.The test result of ferritin was 1170 ng/ml and the test result of esr was 93 at that moment.On (b)(6) 2019, the test result was 8596 ng/ml, the patient was performed anti-infective treatment and antiviral treatment.On (b)(6) 2019, took the dexamethasone 5 mg/ day.On (b)(6) 2019, the test result of ferritin was 1102 ng/ml, however, the symptom of patient was severely bad, and the patient was sent to emergency care.On (b)(6) 2019, the test result of ferritin was >1500 ng/ml and the test result of diluted sample was >30000 ng/ml.The clinic doctor made the diagnosis of hlh, and thought that the test result on (b)(6) 2019 was erroneously low.Then, the sample on (b)(6) 2019 was diluted and the test result was >70000 on the repeated run.Treatment, on (b)(6) ciclosporin, methylprednisolone treatment.On (b)(6), decreased the dosage of methylprednisolone, and remained the rest medicine dosage.On (b)(6), the vital sign was stable.On (b)(6) 2019, the patient was discharged from hospital with medicine description.¿ diagnosis was made via hlh (b)(6) diagnosis and treatment guidance." beckman coulter internal number: case-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ACCESS FERRITIN
Type of Device
RADIOIMMUNOASSAY (TWO-SITE SOLID PHASE), FERRITIN
Manufacturer (Section D)
CHASKA DISCRETE MFG IO
1000 lake hazeltine drive
chaska MN 55318
MDR Report Key8394289
MDR Text Key137943521
Report Number2122870-2019-01051
Device Sequence Number1
Product Code JMG
UDI-Device Identifier15099590575052
UDI-Public(01)15099590575052(17)190731(11)190731(10)831328
Combination Product (y/n)N
PMA/PMN Number
K052082
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Type of Report Initial,Followup
Report Date 05/01/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/06/2019
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Expiration Date07/31/2019
Device Model Number33020
Device Catalogue Number33020
Device Lot Number831328
Was Device Available for Evaluation? No
Date Manufacturer Received04/29/2019
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age23 MO
-
-